Charles Kopel specializes in price-fixing class actions, government records appeals, and qui tam litigation. Together with his colleagues, Mr. Kopel has attained substantial settlements for his clients.
Bond Rigging: Mr. Kopel represents plaintiffs in class actions concerning conspiracies by large banks to fix the prices of bonds issued by governmental and quasi-governmental entities. These actions include: In re European Government Bonds Antitrust Litigation, No. 1:19-CV-02601 (S.D.N.Y.), seeking recovery for U.S. investors in euro-denominated bonds issued by eurozone governments; In re GSE Bonds Antitrust Litigation, No. 1:19-CV-01704 (S.D.N.Y.), seeking recovery for U.S. investors in unsecured bonds issued by U.S. government-sponsored enterprises, including Fannie Mae and Freddie Mac; and In re Mexican Government Bonds Antitrust Litigation, No. 1:18-CV-02830 (S.D.N.Y.), seeking recovery for U.S. investors in Mexican government bonds. Collectively, plaintiffs in these ongoing actions have already reached settlements recovering more than $400 million on behalf of class members.
Benchmark Manipulation: Mr. Kopel also represents plaintiffs in class actions involving banks’ manipulation of interest rate benchmarks, which directly impact the value of benchmark-denominated financial instruments. These actions include Dennis et al. v. JPMorgan Chase & Co. et al., No. 1:16-CV-06496 (S.D.N.Y.), concerning manipulation of the Bank Bill Swap Reference Rate (“BBSW”), an important Australian dollar benchmark, at the expense of U.S.-based investors. Lowey Dannenberg has already reached an agreement to settle the claims against one defendant banking group, JPMorgan Chase & Co. and its affiliates, for $7 million.
Qui Tam: Mr. Kopel represents relators in Cho et al. v. Surgery Partners Inc., et al., No. 8:17-cv-00983 (M.D. Fla.), a suit alleging that network of pain clinics and related laboratories, as well as its private equity owners, participated in a scheme to defraud federal healthcare programs by systematically billing them for medically unnecessary urine drug testing. Several defendants have already settled, agreeing to pay $41 million to resolve the claims.
Prior to joining the firm, Mr. Kopel served as a Legal Intern for the City of Philadelphia Law Department, and as a Law Clerk for the Delaware Department of Justice.
At NYU School of Law, Mr. Kopel served as a Senior Articles Editor of the Journal of International Law and Politics. He also worked as a research assistant to Professor Jose Alvarez, a widely recognized expert of international legal process.
Mr. Kopel, a member of the Philadelphia Bar Association, advises non-profit organizations pro bono. He also contributes academic Jewish studies articles to several publications.
“When a Defendant’s Employee Takes the Fifth During a Deposition,” Lowey Dannenberg Blog, January 7, 2020.
B.A. Yeshiva University (2014), summa cum laude
J.D. New York University School of Law (2017)
United States District Court for the Eastern District of Pennsylvania
United States District Court for the Southern District of New York